Clinical Trial Update: ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer [NA]

View source ↗

Summary

Clinical trial update on ctDNA-guided first-line immuno-de-escalation therapy for stage IVB and recurrent cervical cancer, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Obstetrics & Gynecology Hospital of Fudan University | Conditions: Uterine Cervical Neoplasm | NA | Status: NOT_YET_RECRUITING